4629 — Daishin Chemical Co Balance Sheet
0.000.00%
- ¥7bn
- -¥189m
- ¥35bn
- 82
- 96
- 47
- 91
Annual balance sheet for Daishin Chemical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 5,159 | 4,585 | 5,706 | 4,861 | 7,125 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 9,608 | 12,105 | 11,965 | 12,424 | 11,123 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 15,565 | 17,877 | 18,854 | 18,431 | 19,440 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 4,137 | 3,987 | 4,090 | 4,142 | 3,990 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 21,033 | 23,256 | 24,393 | 24,133 | 25,196 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 6,599 | 8,379 | 8,714 | 7,916 | 8,466 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 7,042 | 8,744 | 8,951 | 8,110 | 8,676 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 13,991 | 14,512 | 15,442 | 16,022 | 16,520 |
| Total Liabilities & Shareholders' Equity | 21,033 | 23,256 | 24,393 | 24,133 | 25,196 |
| Total Common Shares Outstanding |